Donor modification leads to prolonged survival of limb allografts

Plastic and Reconstructive Surgery

Volumn 108, Issue 5, 2001, Pages 1235-1241

  Lee, W P A ^a   Butler, P E M ^a   Randolph, M A ^a   Yaremchuk, M J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ALLOGRAFT; ALLOTRANSPLANTATION; ANIMAL TISSUE; ARTICLE; BONE MARROW; BONE MARROW TRANSPLANTATION; CELLULAR IMMUNITY; CHIMERA; CONTROLLED STUDY; EXPERIMENTAL MODEL; GRAFT SURVIVAL; HUMORAL IMMUNITY; ISOGRAFT; LIMB; MALE; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; RAT;

EID: 0034790071     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006534-200110000-00021     Document Type: Article

References (44)

1. The first transplantation of a band in humans: Early results
2. Human hand allograft: Report on first 6 months
3. Successful hand transplantation: One-year follow-up
4. Vascularized bone allograft transplantation in a genetically defined rat model
5. Experimental orthotopic transplantation of vascularized skeletal allografts: Functional assessment and long-term survival
6. Hand transplantation: Pertinent data and future outlook
7. Relative antigenicity of components of a vascularized limb allograft
8. Histological characteristics of acute rejection in vascularized allografts of bone
9. Immunologic and ultrastructural changes during early rejection of composite tissue allografts
10. Prolonged survival of vascularized limb tissue allografts by donor irradiation
11. Stromal cells in long-term murine bone marrow culture: FACS studies and origin of stromal cells in radiation chimeras
12. Vascular knee allograft transplantation in a rabbit model
13. Rejection of murine cardiac allografts
14. Cell-mediated cytotoxicity, allograft rejection, and tumor immunity
15. Prolongation of allograft survival by cyclosporin A
16. Skin grafts in rabbits with cyclosporin A
17. Cyclosporine prolongs skin allografts in rat burn model
18. Experimental models in primates for reconstructive surgery utilizing tissue transplants
19. Cyclosporine and experimental skin allografts: II. Indefinite survival and development of specific immunologic unresponsiveness
20. Cyclosporine and experimental skin allografts: Long-term survival in rats treated with low maintenance doses
21. Cyclosporin A as a means of preventing rejection of skeletal muscle allografts in mice
22. Muscle allograft survival after cyclosporin A immunosuppression
23. Effects of cyclosporine on the healing of vascularized and non-vascularized bone allografts in rodents
24. The role of cyclosporine in prolonging survival in vascularized bone allografts
25. Failure of cyclosporin A to induce immunological unresponsiveness to nerve allografts
26. Rejection of nerve allografts after cessation of immunosuppression with cyclosporine A
27. Survival of nerve and Schwann cells in allografts after cyclosporine A treatment
28. Modification of experimental limb allograft rejection with cyclosporine and prednisone: A preliminary report
29. Limb allografts in rats immunosuppressed with cyclosporin A
30. Use of cyclosporine A in allotransplantation of rat limbs
31. Composite tissue (limb) allografts in rats: I. Dose-dependent increase in survival with cyclosporine
32. Composite tissue (limb) allografts in rats: II. Indefinite survival using low-dose cyclosporine
33. Growth of forelimb allografts in young rabbits immunosuppressed with cyclosporine
34. Selective transplantation: An emerging concept
35. Organ transplantation (skin, kidney, heart) and the plastic surgeon
36. Activity of cyclosporin-A in skin graft rejection and in graft-versus-host disease in rabbits
37. Studies on human epidermal Langerhans' cells: I. Allo-activating and antigen-presenting capacity
38. Antigen presentation by murine epidermal Langerhans' cells and its alteration by ultraviolet B light
39. A depression technique of the epidermal Langerhans' cells in cadaver split skin
40. Canine limb homotransplantation
41. Neonatal induction of tolerance to skeletal tissue allografts without immunosuppression
42. Skin allograft survival following intrathymic injection of donor bone marrow
43. Use of swine model in transplantation of vascularized skeletal tissue allografts
44. Tolerance to limb tissue allografts between swine matched for major histocompatibility, complex antigens